Duško Lainšček
researcherMale0.0Global Dominance: 0.00%
Duško Lainšček is a researcher at the Chemical Institute who contributed to the development of the gene therapy for CTNNB1 syndrome. His work involved collaborative efforts across multiple research institutions, focusing on the safe delivery of gene therapy and the scientific validation of its therapeutic effects.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Duško Lainšček explained that the development of gene therapy involved teamwork from many research institutions.
Deček Urban je prvi prejemnik genske terapije za sindrom CTNNB1Delo – major Slovenian daily, est. 1959·
Slovenia· 2025-12-19
Slovenia· 2025-12-19
